Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019

Market: Pharmaceuticals and Healthcare

Global, 85 pages report, published by Global Markets Direct

Report ThumbnailMarch-2019
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy - Pipeline Review, H1 2019, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (Central Nervous System) pipeline landscape.

Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as chronic relapsing polyneuropathy is a neurologic

Read More
  • List of Figures
  • Number of Products under Development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products by Targets, H1 2019
  • Number of Products by Stage and Targets, H1 2019
  • Number of Products by Mechanism of Actions, H1 2019
  • Number of Products by Stage and Mechanism of Actions, H1 2019
  • Number of Products by Routes of Administration, H1 2019
  • Number of Products by Stage and Routes of Administration, H1
Read More
  • List of Tables
  • Number of Products under Development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Products under Development by Companies, H1 2019
  • Number of Products by Stage and Target, H1 2019
  • Number of Products by Stage and Mechanism of Action, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Chronic Inflammatory Demyelinating Polyne
Read More
  • Table of Contents
  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Overview
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Products under Development by Companies
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Adminis
Read More

Please select a license type

Share

Related Products

Global Markets DirectChronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019Product ThumbnailChronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2019, Industry ReportProduct #: 1197281
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved